Breakout Session #2

Focus on Hematopathology

Saturday, April 12 | 2–3 p.m.

Description to come.


Lab Safety or Challenges Myeloid Malignancies Testing for NGS and QC

Charles Hill, M.D., Ph.D., Emory University School of Medicine

Description to come.

Dollars and Sense

Annette Kim, M.D., Ph.D., University of Michigan School of Medicine

This presentation will cover simple point-of-care or plug-and-play methods in molecular diagnostics that can provide adequate and timely care of patients in resource-limited settings. It will reference the WHO Essential Medicines and Essential Diagnostics Lists and discuss non-NGS methods to address these minimum and more broad molecular needs in germline disease and oncology indications. In addition, thoughts on how to maximize available platforms and use of testing algorithms for efficient testing practices will be shared.

 

See the full schedule

The program includes sessions, networking opportunities, industry spotlights and more.

View program

AMP Corporate Partners

Diamond Partner

Roche Diagnostics

Platinum Partner

Gold Partners

Abbvie
Amgen
Biotechne/Asuragen
Bristol Meyers Squibb
Illumina
Loxo
Merck
Pfizer

Silver Partners

Agilent
AstraZeneca